nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—Vaginal inflammation—Methotrexate—esophageal cancer	0.00215	0.00313	CcSEcCtD
Donepezil—Myocardial infarction—Cisplatin—esophageal cancer	0.00215	0.00313	CcSEcCtD
Donepezil—Cardiac failure—Capecitabine—esophageal cancer	0.00215	0.00313	CcSEcCtD
Donepezil—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00214	0.00312	CcSEcCtD
Donepezil—Conjunctivitis—Cisplatin—esophageal cancer	0.00214	0.0031	CcSEcCtD
Donepezil—Hyponatraemia—Capecitabine—esophageal cancer	0.00211	0.00306	CcSEcCtD
Donepezil—Melaena—Methotrexate—esophageal cancer	0.0021	0.00306	CcSEcCtD
Donepezil—Cystitis noninfective—Methotrexate—esophageal cancer	0.0021	0.00306	CcSEcCtD
Donepezil—Osteoarthritis—Capecitabine—esophageal cancer	0.0021	0.00305	CcSEcCtD
Donepezil—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.0021	0.00305	CcSEcCtD
Donepezil—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00208	0.00303	CcSEcCtD
Donepezil—Cystitis—Methotrexate—esophageal cancer	0.00208	0.00302	CcSEcCtD
Donepezil—Vaginal infection—Methotrexate—esophageal cancer	0.00203	0.00296	CcSEcCtD
Donepezil—Face oedema—Capecitabine—esophageal cancer	0.00203	0.00295	CcSEcCtD
Donepezil—Bradycardia—Cisplatin—esophageal cancer	0.00201	0.00292	CcSEcCtD
Donepezil—Irritability—Capecitabine—esophageal cancer	0.00201	0.00291	CcSEcCtD
Donepezil—Urinary retention—Capecitabine—esophageal cancer	0.002	0.0029	CcSEcCtD
Donepezil—Mood swings—Capecitabine—esophageal cancer	0.00199	0.00289	CcSEcCtD
Donepezil—Ataxia—Capecitabine—esophageal cancer	0.00198	0.00287	CcSEcCtD
Donepezil—Blood creatinine increased—Capecitabine—esophageal cancer	0.00197	0.00286	CcSEcCtD
Donepezil—Dehydration—Capecitabine—esophageal cancer	0.00195	0.00284	CcSEcCtD
Donepezil—Ecchymosis—Methotrexate—esophageal cancer	0.00195	0.00283	CcSEcCtD
Donepezil—Bladder pain—Methotrexate—esophageal cancer	0.00195	0.00283	CcSEcCtD
Donepezil—Urinary tract disorder—Cisplatin—esophageal cancer	0.00195	0.00283	CcSEcCtD
Donepezil—Liver function test abnormal—Capecitabine—esophageal cancer	0.00194	0.00282	CcSEcCtD
Donepezil—Urethral disorder—Cisplatin—esophageal cancer	0.00193	0.00281	CcSEcCtD
Donepezil—Dry skin—Capecitabine—esophageal cancer	0.00193	0.0028	CcSEcCtD
Donepezil—Abdominal pain upper—Capecitabine—esophageal cancer	0.00192	0.00279	CcSEcCtD
Donepezil—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00192	0.00279	CcSEcCtD
Donepezil—Hypokalaemia—Capecitabine—esophageal cancer	0.00191	0.00278	CcSEcCtD
Donepezil—Visual impairment—Cisplatin—esophageal cancer	0.0019	0.00276	CcSEcCtD
Donepezil—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00189	0.00275	CcSEcCtD
Donepezil—Nasopharyngitis—Capecitabine—esophageal cancer	0.00188	0.00273	CcSEcCtD
Donepezil—Sepsis—Methotrexate—esophageal cancer	0.00187	0.00272	CcSEcCtD
Donepezil—Gastritis—Capecitabine—esophageal cancer	0.00186	0.0027	CcSEcCtD
Donepezil—Muscular weakness—Capecitabine—esophageal cancer	0.00185	0.00269	CcSEcCtD
Donepezil—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00185	0.00269	CcSEcCtD
Donepezil—Tinnitus—Cisplatin—esophageal cancer	0.00184	0.00267	CcSEcCtD
Donepezil—Abdominal distension—Capecitabine—esophageal cancer	0.00183	0.00266	CcSEcCtD
Donepezil—Dysphagia—Capecitabine—esophageal cancer	0.00182	0.00264	CcSEcCtD
Donepezil—Asthma—Capecitabine—esophageal cancer	0.00182	0.00264	CcSEcCtD
Donepezil—Influenza—Capecitabine—esophageal cancer	0.00182	0.00264	CcSEcCtD
Donepezil—Diabetes mellitus—Methotrexate—esophageal cancer	0.0018	0.00261	CcSEcCtD
Donepezil—Sweating increased—Capecitabine—esophageal cancer	0.00177	0.00257	CcSEcCtD
Donepezil—Angina pectoris—Capecitabine—esophageal cancer	0.00177	0.00257	CcSEcCtD
Donepezil—Arrhythmia—Cisplatin—esophageal cancer	0.00176	0.00256	CcSEcCtD
Donepezil—Bronchitis—Capecitabine—esophageal cancer	0.00175	0.00254	CcSEcCtD
Donepezil—Alopecia—Cisplatin—esophageal cancer	0.00174	0.00253	CcSEcCtD
Donepezil—Abdominal discomfort—Capecitabine—esophageal cancer	0.00174	0.00253	CcSEcCtD
Donepezil—Malnutrition—Cisplatin—esophageal cancer	0.00172	0.00249	CcSEcCtD
Donepezil—Erythema—Cisplatin—esophageal cancer	0.00172	0.00249	CcSEcCtD
Donepezil—Dysuria—Capecitabine—esophageal cancer	0.0017	0.00247	CcSEcCtD
Donepezil—Flatulence—Cisplatin—esophageal cancer	0.00169	0.00246	CcSEcCtD
Donepezil—Weight increased—Capecitabine—esophageal cancer	0.00165	0.0024	CcSEcCtD
Donepezil—Muscle spasms—Cisplatin—esophageal cancer	0.00165	0.0024	CcSEcCtD
Donepezil—Weight decreased—Capecitabine—esophageal cancer	0.00164	0.00239	CcSEcCtD
Donepezil—Hyperglycaemia—Capecitabine—esophageal cancer	0.00164	0.00238	CcSEcCtD
Donepezil—Pneumonia—Capecitabine—esophageal cancer	0.00163	0.00237	CcSEcCtD
Donepezil—Infestation—Capecitabine—esophageal cancer	0.00162	0.00235	CcSEcCtD
Donepezil—Infestation NOS—Capecitabine—esophageal cancer	0.00162	0.00235	CcSEcCtD
Donepezil—Vision blurred—Cisplatin—esophageal cancer	0.00162	0.00235	CcSEcCtD
Donepezil—Depression—Capecitabine—esophageal cancer	0.00161	0.00235	CcSEcCtD
Donepezil—Tremor—Cisplatin—esophageal cancer	0.00161	0.00234	CcSEcCtD
Donepezil—Acute coronary syndrome—Capecitabine—esophageal cancer	0.0016	0.00232	CcSEcCtD
Donepezil—Cerebrovascular accident—Methotrexate—esophageal cancer	0.0016	0.00232	CcSEcCtD
Donepezil—Ill-defined disorder—Cisplatin—esophageal cancer	0.00159	0.00231	CcSEcCtD
Donepezil—Renal failure—Capecitabine—esophageal cancer	0.00159	0.00231	CcSEcCtD
Donepezil—Myocardial infarction—Capecitabine—esophageal cancer	0.00159	0.00231	CcSEcCtD
Donepezil—Anaemia—Cisplatin—esophageal cancer	0.00159	0.0023	CcSEcCtD
Donepezil—Jaundice—Capecitabine—esophageal cancer	0.00158	0.00229	CcSEcCtD
Donepezil—Conjunctivitis—Capecitabine—esophageal cancer	0.00157	0.00229	CcSEcCtD
Donepezil—Urinary tract infection—Capecitabine—esophageal cancer	0.00157	0.00229	CcSEcCtD
Donepezil—Osteoarthritis—Methotrexate—esophageal cancer	0.00156	0.00227	CcSEcCtD
Donepezil—Malaise—Cisplatin—esophageal cancer	0.00155	0.00225	CcSEcCtD
Donepezil—Haematuria—Capecitabine—esophageal cancer	0.00154	0.00224	CcSEcCtD
Donepezil—Epistaxis—Capecitabine—esophageal cancer	0.00153	0.00222	CcSEcCtD
Donepezil—Irritability—Methotrexate—esophageal cancer	0.00149	0.00217	CcSEcCtD
Donepezil—Convulsion—Cisplatin—esophageal cancer	0.00149	0.00216	CcSEcCtD
Donepezil—Mood swings—Methotrexate—esophageal cancer	0.00148	0.00215	CcSEcCtD
Donepezil—Bradycardia—Capecitabine—esophageal cancer	0.00148	0.00215	CcSEcCtD
Donepezil—Ataxia—Methotrexate—esophageal cancer	0.00147	0.00214	CcSEcCtD
Donepezil—Myalgia—Cisplatin—esophageal cancer	0.00146	0.00212	CcSEcCtD
Donepezil—Haemoglobin—Capecitabine—esophageal cancer	0.00146	0.00212	CcSEcCtD
Donepezil—Rhinitis—Capecitabine—esophageal cancer	0.00146	0.00212	CcSEcCtD
Donepezil—Anxiety—Cisplatin—esophageal cancer	0.00146	0.00212	CcSEcCtD
Donepezil—Haemorrhage—Capecitabine—esophageal cancer	0.00145	0.00211	CcSEcCtD
Donepezil—Hepatitis—Capecitabine—esophageal cancer	0.00145	0.00211	CcSEcCtD
Donepezil—Hypoaesthesia—Capecitabine—esophageal cancer	0.00145	0.0021	CcSEcCtD
Donepezil—Liver function test abnormal—Methotrexate—esophageal cancer	0.00144	0.0021	CcSEcCtD
Donepezil—Discomfort—Cisplatin—esophageal cancer	0.00144	0.0021	CcSEcCtD
Donepezil—Pharyngitis—Capecitabine—esophageal cancer	0.00144	0.0021	CcSEcCtD
Donepezil—Urinary tract disorder—Capecitabine—esophageal cancer	0.00144	0.00209	CcSEcCtD
Donepezil—Oedema peripheral—Capecitabine—esophageal cancer	0.00143	0.00208	CcSEcCtD
Donepezil—Urethral disorder—Capecitabine—esophageal cancer	0.00142	0.00207	CcSEcCtD
Donepezil—Oedema—Cisplatin—esophageal cancer	0.0014	0.00204	CcSEcCtD
Donepezil—Visual impairment—Capecitabine—esophageal cancer	0.0014	0.00204	CcSEcCtD
Donepezil—Infection—Cisplatin—esophageal cancer	0.00139	0.00202	CcSEcCtD
Donepezil—Nervous system disorder—Cisplatin—esophageal cancer	0.00137	0.002	CcSEcCtD
Donepezil—Thrombocytopenia—Cisplatin—esophageal cancer	0.00137	0.00199	CcSEcCtD
Donepezil—Tinnitus—Capecitabine—esophageal cancer	0.00136	0.00197	CcSEcCtD
Donepezil—Hyperhidrosis—Cisplatin—esophageal cancer	0.00135	0.00197	CcSEcCtD
Donepezil—Asthma—Methotrexate—esophageal cancer	0.00135	0.00196	CcSEcCtD
Donepezil—Eosinophilia—Methotrexate—esophageal cancer	0.00134	0.00194	CcSEcCtD
Donepezil—Anorexia—Cisplatin—esophageal cancer	0.00134	0.00194	CcSEcCtD
Donepezil—Pancreatitis—Methotrexate—esophageal cancer	0.00133	0.00193	CcSEcCtD
Donepezil—Hypotension—Cisplatin—esophageal cancer	0.00131	0.0019	CcSEcCtD
Donepezil—Chills—Capecitabine—esophageal cancer	0.0013	0.00189	CcSEcCtD
Donepezil—Arrhythmia—Capecitabine—esophageal cancer	0.0013	0.00189	CcSEcCtD
Donepezil—Abdominal discomfort—Methotrexate—esophageal cancer	0.0013	0.00188	CcSEcCtD
Donepezil—Alopecia—Capecitabine—esophageal cancer	0.00128	0.00187	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00128	0.00185	CcSEcCtD
Donepezil—Mental disorder—Capecitabine—esophageal cancer	0.00127	0.00185	CcSEcCtD
Donepezil—Erythema—Capecitabine—esophageal cancer	0.00127	0.00184	CcSEcCtD
Donepezil—Malnutrition—Capecitabine—esophageal cancer	0.00127	0.00184	CcSEcCtD
Donepezil—Dysuria—Methotrexate—esophageal cancer	0.00126	0.00184	CcSEcCtD
Donepezil—Paraesthesia—Cisplatin—esophageal cancer	0.00126	0.00183	CcSEcCtD
Donepezil—Dyspnoea—Cisplatin—esophageal cancer	0.00125	0.00181	CcSEcCtD
Donepezil—Flatulence—Capecitabine—esophageal cancer	0.00125	0.00181	CcSEcCtD
Donepezil—Dysgeusia—Capecitabine—esophageal cancer	0.00124	0.0018	CcSEcCtD
Donepezil—Back pain—Capecitabine—esophageal cancer	0.00122	0.00178	CcSEcCtD
Donepezil—Decreased appetite—Cisplatin—esophageal cancer	0.00122	0.00177	CcSEcCtD
Donepezil—Muscle spasms—Capecitabine—esophageal cancer	0.00122	0.00177	CcSEcCtD
Donepezil—Pneumonia—Methotrexate—esophageal cancer	0.00121	0.00176	CcSEcCtD
Donepezil—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00121	0.00176	CcSEcCtD
Donepezil—Infestation NOS—Methotrexate—esophageal cancer	0.00121	0.00175	CcSEcCtD
Donepezil—Infestation—Methotrexate—esophageal cancer	0.00121	0.00175	CcSEcCtD
Donepezil—Depression—Methotrexate—esophageal cancer	0.0012	0.00175	CcSEcCtD
Donepezil—Pain—Cisplatin—esophageal cancer	0.0012	0.00174	CcSEcCtD
Donepezil—Vision blurred—Capecitabine—esophageal cancer	0.00119	0.00173	CcSEcCtD
Donepezil—Tremor—Capecitabine—esophageal cancer	0.00119	0.00172	CcSEcCtD
Donepezil—Renal failure—Methotrexate—esophageal cancer	0.00118	0.00172	CcSEcCtD
Donepezil—Ill-defined disorder—Capecitabine—esophageal cancer	0.00117	0.00171	CcSEcCtD
Donepezil—Conjunctivitis—Methotrexate—esophageal cancer	0.00117	0.0017	CcSEcCtD
Donepezil—Anaemia—Capecitabine—esophageal cancer	0.00117	0.0017	CcSEcCtD
Donepezil—Sweating—Methotrexate—esophageal cancer	0.00116	0.00168	CcSEcCtD
Donepezil—Feeling abnormal—Cisplatin—esophageal cancer	0.00115	0.00168	CcSEcCtD
Donepezil—Haematuria—Methotrexate—esophageal cancer	0.00115	0.00167	CcSEcCtD
Donepezil—Malaise—Capecitabine—esophageal cancer	0.00114	0.00166	CcSEcCtD
Donepezil—Epistaxis—Methotrexate—esophageal cancer	0.00114	0.00165	CcSEcCtD
Donepezil—Vertigo—Capecitabine—esophageal cancer	0.00114	0.00165	CcSEcCtD
Donepezil—Syncope—Capecitabine—esophageal cancer	0.00113	0.00165	CcSEcCtD
Donepezil—Loss of consciousness—Capecitabine—esophageal cancer	0.00111	0.00162	CcSEcCtD
Donepezil—Body temperature increased—Cisplatin—esophageal cancer	0.00111	0.00161	CcSEcCtD
Donepezil—Cough—Capecitabine—esophageal cancer	0.0011	0.0016	CcSEcCtD
Donepezil—Hypertension—Capecitabine—esophageal cancer	0.00109	0.00159	CcSEcCtD
Donepezil—Haemoglobin—Methotrexate—esophageal cancer	0.00109	0.00158	CcSEcCtD
Donepezil—Haemorrhage—Methotrexate—esophageal cancer	0.00108	0.00157	CcSEcCtD
Donepezil—Hepatitis—Methotrexate—esophageal cancer	0.00108	0.00157	CcSEcCtD
Donepezil—Arthralgia—Capecitabine—esophageal cancer	0.00108	0.00157	CcSEcCtD
Donepezil—Chest pain—Capecitabine—esophageal cancer	0.00108	0.00157	CcSEcCtD
Donepezil—Myalgia—Capecitabine—esophageal cancer	0.00108	0.00157	CcSEcCtD
Donepezil—Pharyngitis—Methotrexate—esophageal cancer	0.00107	0.00156	CcSEcCtD
Donepezil—Anxiety—Capecitabine—esophageal cancer	0.00107	0.00156	CcSEcCtD
Donepezil—Urinary tract disorder—Methotrexate—esophageal cancer	0.00107	0.00155	CcSEcCtD
Donepezil—Discomfort—Capecitabine—esophageal cancer	0.00106	0.00155	CcSEcCtD
Donepezil—Urethral disorder—Methotrexate—esophageal cancer	0.00106	0.00154	CcSEcCtD
Donepezil—Dry mouth—Capecitabine—esophageal cancer	0.00105	0.00153	CcSEcCtD
Donepezil—Visual impairment—Methotrexate—esophageal cancer	0.00104	0.00151	CcSEcCtD
Donepezil—Confusional state—Capecitabine—esophageal cancer	0.00104	0.00151	CcSEcCtD
Donepezil—Oedema—Capecitabine—esophageal cancer	0.00103	0.0015	CcSEcCtD
Donepezil—Hypersensitivity—Cisplatin—esophageal cancer	0.00103	0.0015	CcSEcCtD
Donepezil—Infection—Capecitabine—esophageal cancer	0.00103	0.00149	CcSEcCtD
Donepezil—Shock—Capecitabine—esophageal cancer	0.00102	0.00148	CcSEcCtD
Donepezil—Nervous system disorder—Capecitabine—esophageal cancer	0.00101	0.00147	CcSEcCtD
Donepezil—Thrombocytopenia—Capecitabine—esophageal cancer	0.00101	0.00147	CcSEcCtD
Donepezil—Tinnitus—Methotrexate—esophageal cancer	0.00101	0.00147	CcSEcCtD
Donepezil—Asthenia—Cisplatin—esophageal cancer	0.00101	0.00146	CcSEcCtD
Donepezil—Hyperhidrosis—Capecitabine—esophageal cancer	0.000998	0.00145	CcSEcCtD
Donepezil—Anorexia—Capecitabine—esophageal cancer	0.000984	0.00143	CcSEcCtD
Donepezil—Chills—Methotrexate—esophageal cancer	0.000971	0.00141	CcSEcCtD
Donepezil—Hypotension—Capecitabine—esophageal cancer	0.000965	0.0014	CcSEcCtD
Donepezil—Diarrhoea—Cisplatin—esophageal cancer	0.000959	0.00139	CcSEcCtD
Donepezil—Alopecia—Methotrexate—esophageal cancer	0.000956	0.00139	CcSEcCtD
Donepezil—Mental disorder—Methotrexate—esophageal cancer	0.000948	0.00138	CcSEcCtD
Donepezil—Malnutrition—Methotrexate—esophageal cancer	0.000942	0.00137	CcSEcCtD
Donepezil—Erythema—Methotrexate—esophageal cancer	0.000942	0.00137	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000941	0.00137	CcSEcCtD
Donepezil—Insomnia—Capecitabine—esophageal cancer	0.000934	0.00136	CcSEcCtD
Donepezil—Paraesthesia—Capecitabine—esophageal cancer	0.000927	0.00135	CcSEcCtD
Donepezil—Dysgeusia—Methotrexate—esophageal cancer	0.000922	0.00134	CcSEcCtD
Donepezil—Dyspnoea—Capecitabine—esophageal cancer	0.000921	0.00134	CcSEcCtD
Donepezil—Back pain—Methotrexate—esophageal cancer	0.000911	0.00132	CcSEcCtD
Donepezil—Dyspepsia—Capecitabine—esophageal cancer	0.000909	0.00132	CcSEcCtD
Donepezil—Decreased appetite—Capecitabine—esophageal cancer	0.000898	0.0013	CcSEcCtD
Donepezil—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000892	0.0013	CcSEcCtD
Donepezil—Vomiting—Cisplatin—esophageal cancer	0.000891	0.00129	CcSEcCtD
Donepezil—Fatigue—Capecitabine—esophageal cancer	0.00089	0.00129	CcSEcCtD
Donepezil—Vision blurred—Methotrexate—esophageal cancer	0.000888	0.00129	CcSEcCtD
Donepezil—Rash—Cisplatin—esophageal cancer	0.000883	0.00128	CcSEcCtD
Donepezil—Constipation—Capecitabine—esophageal cancer	0.000883	0.00128	CcSEcCtD
Donepezil—Pain—Capecitabine—esophageal cancer	0.000883	0.00128	CcSEcCtD
Donepezil—Dermatitis—Cisplatin—esophageal cancer	0.000883	0.00128	CcSEcCtD
Donepezil—Ill-defined disorder—Methotrexate—esophageal cancer	0.000874	0.00127	CcSEcCtD
Donepezil—Anaemia—Methotrexate—esophageal cancer	0.000871	0.00126	CcSEcCtD
Donepezil—Feeling abnormal—Capecitabine—esophageal cancer	0.000851	0.00124	CcSEcCtD
Donepezil—Malaise—Methotrexate—esophageal cancer	0.000849	0.00123	CcSEcCtD
Donepezil—Vertigo—Methotrexate—esophageal cancer	0.000846	0.00123	CcSEcCtD
Donepezil—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000845	0.00123	CcSEcCtD
Donepezil—Nausea—Cisplatin—esophageal cancer	0.000832	0.00121	CcSEcCtD
Donepezil—Cough—Methotrexate—esophageal cancer	0.000822	0.00119	CcSEcCtD
Donepezil—Urticaria—Capecitabine—esophageal cancer	0.00082	0.00119	CcSEcCtD
Donepezil—Abdominal pain—Capecitabine—esophageal cancer	0.000816	0.00119	CcSEcCtD
Donepezil—Body temperature increased—Capecitabine—esophageal cancer	0.000816	0.00119	CcSEcCtD
Donepezil—Convulsion—Methotrexate—esophageal cancer	0.000816	0.00119	CcSEcCtD
Donepezil—Arthralgia—Methotrexate—esophageal cancer	0.000802	0.00117	CcSEcCtD
Donepezil—Chest pain—Methotrexate—esophageal cancer	0.000802	0.00117	CcSEcCtD
Donepezil—Myalgia—Methotrexate—esophageal cancer	0.000802	0.00117	CcSEcCtD
Donepezil—Discomfort—Methotrexate—esophageal cancer	0.000792	0.00115	CcSEcCtD
Donepezil—Confusional state—Methotrexate—esophageal cancer	0.000775	0.00113	CcSEcCtD
Donepezil—Infection—Methotrexate—esophageal cancer	0.000764	0.00111	CcSEcCtD
Donepezil—Hypersensitivity—Capecitabine—esophageal cancer	0.000761	0.00111	CcSEcCtD
Donepezil—Nervous system disorder—Methotrexate—esophageal cancer	0.000754	0.0011	CcSEcCtD
Donepezil—Thrombocytopenia—Methotrexate—esophageal cancer	0.000753	0.00109	CcSEcCtD
Donepezil—Hyperhidrosis—Methotrexate—esophageal cancer	0.000743	0.00108	CcSEcCtD
Donepezil—Asthenia—Capecitabine—esophageal cancer	0.000741	0.00108	CcSEcCtD
Donepezil—Anorexia—Methotrexate—esophageal cancer	0.000733	0.00106	CcSEcCtD
Donepezil—Pruritus—Capecitabine—esophageal cancer	0.000731	0.00106	CcSEcCtD
Donepezil—Hypotension—Methotrexate—esophageal cancer	0.000718	0.00104	CcSEcCtD
Donepezil—Diarrhoea—Capecitabine—esophageal cancer	0.000707	0.00103	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.0007	0.00102	CcSEcCtD
Donepezil—Insomnia—Methotrexate—esophageal cancer	0.000695	0.00101	CcSEcCtD
Donepezil—Paraesthesia—Methotrexate—esophageal cancer	0.00069	0.001	CcSEcCtD
Donepezil—Dyspnoea—Methotrexate—esophageal cancer	0.000685	0.000996	CcSEcCtD
Donepezil—Somnolence—Methotrexate—esophageal cancer	0.000683	0.000993	CcSEcCtD
Donepezil—Dizziness—Capecitabine—esophageal cancer	0.000683	0.000992	CcSEcCtD
Donepezil—Dyspepsia—Methotrexate—esophageal cancer	0.000677	0.000983	CcSEcCtD
Donepezil—Decreased appetite—Methotrexate—esophageal cancer	0.000668	0.000971	CcSEcCtD
Donepezil—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000664	0.000964	CcSEcCtD
Donepezil—Fatigue—Methotrexate—esophageal cancer	0.000663	0.000963	CcSEcCtD
Donepezil—Pain—Methotrexate—esophageal cancer	0.000657	0.000955	CcSEcCtD
Donepezil—Vomiting—Capecitabine—esophageal cancer	0.000657	0.000954	CcSEcCtD
Donepezil—Rash—Capecitabine—esophageal cancer	0.000651	0.000946	CcSEcCtD
Donepezil—Dermatitis—Capecitabine—esophageal cancer	0.000651	0.000945	CcSEcCtD
Donepezil—Headache—Capecitabine—esophageal cancer	0.000647	0.00094	CcSEcCtD
Donepezil—Feeling abnormal—Methotrexate—esophageal cancer	0.000634	0.00092	CcSEcCtD
Donepezil—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000629	0.000913	CcSEcCtD
Donepezil—Nausea—Capecitabine—esophageal cancer	0.000613	0.000891	CcSEcCtD
Donepezil—Urticaria—Methotrexate—esophageal cancer	0.000611	0.000887	CcSEcCtD
Donepezil—Abdominal pain—Methotrexate—esophageal cancer	0.000608	0.000883	CcSEcCtD
Donepezil—Body temperature increased—Methotrexate—esophageal cancer	0.000608	0.000883	CcSEcCtD
Donepezil—Hypersensitivity—Methotrexate—esophageal cancer	0.000566	0.000823	CcSEcCtD
Donepezil—Asthenia—Methotrexate—esophageal cancer	0.000552	0.000801	CcSEcCtD
Donepezil—Pruritus—Methotrexate—esophageal cancer	0.000544	0.00079	CcSEcCtD
Donepezil—Diarrhoea—Methotrexate—esophageal cancer	0.000526	0.000764	CcSEcCtD
Donepezil—Dizziness—Methotrexate—esophageal cancer	0.000508	0.000739	CcSEcCtD
Donepezil—Vomiting—Methotrexate—esophageal cancer	0.000489	0.00071	CcSEcCtD
Donepezil—Rash—Methotrexate—esophageal cancer	0.000485	0.000704	CcSEcCtD
Donepezil—Dermatitis—Methotrexate—esophageal cancer	0.000484	0.000704	CcSEcCtD
Donepezil—Headache—Methotrexate—esophageal cancer	0.000482	0.0007	CcSEcCtD
Donepezil—Nausea—Methotrexate—esophageal cancer	0.000457	0.000663	CcSEcCtD
Donepezil—HTR2A—GPCR ligand binding—ANXA1—esophageal cancer	0.000321	0.00103	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000319	0.00102	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CTNNA1—esophageal cancer	0.000318	0.00102	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CXCL2—esophageal cancer	0.000316	0.00101	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CALR—esophageal cancer	0.000315	0.00101	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—SST—esophageal cancer	0.000312	0.001	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ADH7—esophageal cancer	0.000311	0.000999	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PLCE1—esophageal cancer	0.000311	0.000999	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—GHRL—esophageal cancer	0.000309	0.000992	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000309	0.000991	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000308	0.000988	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—FBXW7—esophageal cancer	0.000304	0.000976	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—GHRL—esophageal cancer	0.000304	0.000976	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000302	0.000968	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PSME1—esophageal cancer	0.000295	0.000947	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PSME2—esophageal cancer	0.000295	0.000947	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000294	0.000943	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ANXA1—esophageal cancer	0.000294	0.000943	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000287	0.000921	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SST—esophageal cancer	0.000286	0.000917	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000284	0.00091	CbGpPWpGaD
Donepezil—ACHE—Phospholipid metabolism—PIK3CA—esophageal cancer	0.000282	0.000905	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NOTCH3—esophageal cancer	0.000279	0.000894	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—GHRL—esophageal cancer	0.000279	0.000894	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—FBXW7—esophageal cancer	0.000274	0.000879	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ADH1B—esophageal cancer	0.000273	0.000876	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000269	0.000863	CbGpPWpGaD
Donepezil—ACHE—Metabolism—TYMP—esophageal cancer	0.000261	0.000837	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000256	0.000822	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKAP13—esophageal cancer	0.000254	0.000817	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP26A1—esophageal cancer	0.000254	0.000814	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.00025	0.000804	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NOTCH2—esophageal cancer	0.00025	0.000802	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALOX15—esophageal cancer	0.000247	0.000794	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000239	0.000767	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KMT2D—esophageal cancer	0.000238	0.000763	CbGpPWpGaD
Donepezil—ACHE—Metabolism—TPI1—esophageal cancer	0.000236	0.000757	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTO1—esophageal cancer	0.000236	0.000757	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PDE4D—esophageal cancer	0.000233	0.000747	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKAP13—esophageal cancer	0.000231	0.000742	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000229	0.000734	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALDOB—esophageal cancer	0.000226	0.000726	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000226	0.000725	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000225	0.000723	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TGFBR2—esophageal cancer	0.000222	0.000711	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—GNG7—esophageal cancer	0.000221	0.00071	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GAPDH—esophageal cancer	0.000218	0.000699	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000217	0.000697	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CRABP1—esophageal cancer	0.000216	0.000692	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000215	0.00069	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000212	0.00068	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADCYAP1—esophageal cancer	0.000212	0.00068	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PDE4D—esophageal cancer	0.000211	0.000678	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.00021	0.000675	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SMAD4—esophageal cancer	0.00021	0.000673	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GNG7—esophageal cancer	0.000205	0.000659	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—GNG7—esophageal cancer	0.000201	0.000645	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000197	0.000632	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL2—esophageal cancer	0.000195	0.000626	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—WWOX—esophageal cancer	0.000194	0.000622	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALDH2—esophageal cancer	0.000192	0.000617	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FKBP1A—esophageal cancer	0.000184	0.000591	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTT1—esophageal cancer	0.000183	0.000587	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—ANXA1—esophageal cancer	0.000181	0.000582	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP2A6—esophageal cancer	0.000181	0.00058	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.00018	0.000578	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—WIF1—esophageal cancer	0.00018	0.000578	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL2—esophageal cancer	0.000177	0.000568	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000177	0.000567	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000177	0.000567	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—SST—esophageal cancer	0.000176	0.000566	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000175	0.000562	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000175	0.000562	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—GHRL—esophageal cancer	0.000172	0.000552	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HIF1A—esophageal cancer	0.000172	0.000551	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS1—esophageal cancer	0.000171	0.00055	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ENO1—esophageal cancer	0.000171	0.00055	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PSME2—esophageal cancer	0.000169	0.000542	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PSME1—esophageal cancer	0.000169	0.000542	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CSNK1A1—esophageal cancer	0.000166	0.000533	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—ANXA1—esophageal cancer	0.000165	0.000528	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KDR—esophageal cancer	0.000164	0.000527	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—SST—esophageal cancer	0.00016	0.000514	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000158	0.000506	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000157	0.000502	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—GHRL—esophageal cancer	0.000156	0.000501	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PFN1—esophageal cancer	0.000155	0.000499	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NOTCH1—esophageal cancer	0.000155	0.000496	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000153	0.000491	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CA1—esophageal cancer	0.00015	0.000482	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.00015	0.000482	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CA1—esophageal cancer	0.000149	0.000478	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000149	0.000478	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000148	0.000473	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP1B1—esophageal cancer	0.000146	0.000468	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CREBBP—esophageal cancer	0.00014	0.00045	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ELMO1—esophageal cancer	0.00014	0.000448	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—EGFR—esophageal cancer	0.000138	0.000442	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CA2—esophageal cancer	0.000137	0.000441	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP19A1—esophageal cancer	0.000137	0.00044	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000137	0.000439	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKAP13—esophageal cancer	0.000137	0.000438	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CA2—esophageal cancer	0.000136	0.000437	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000133	0.000427	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000132	0.000423	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000128	0.00041	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000128	0.00041	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PLCE1—esophageal cancer	0.000127	0.000406	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ADH7—esophageal cancer	0.000127	0.000406	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000126	0.000404	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NOS3—esophageal cancer	0.000126	0.000403	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000125	0.000402	CbGpPWpGaD
Donepezil—ACHE—Metabolism—HMOX1—esophageal cancer	0.000125	0.000401	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PDE4D—esophageal cancer	0.000125	0.000401	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000123	0.000394	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ABCB1—esophageal cancer	0.00012	0.000385	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PIK3CA—esophageal cancer	0.00012	0.000384	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GNG7—esophageal cancer	0.000119	0.000381	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ERBB2—esophageal cancer	0.000117	0.000377	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000115	0.000371	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000115	0.000371	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000112	0.000359	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—XIAP—esophageal cancer	0.000111	0.000357	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ADH1B—esophageal cancer	0.000111	0.000356	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000107	0.000343	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TYMP—esophageal cancer	0.000106	0.00034	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CTNNA1—esophageal cancer	0.000105	0.000338	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL2—esophageal cancer	0.000105	0.000336	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000104	0.000334	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CCND1—esophageal cancer	0.000104	0.000333	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP26A1—esophageal cancer	0.000103	0.000331	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000101	0.000326	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALOX15—esophageal cancer	0.000101	0.000323	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CDKN1A—esophageal cancer	0.0001	0.000322	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CA1—esophageal cancer	9.82e-05	0.000315	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC10A2—esophageal cancer	9.82e-05	0.000315	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PSME1—esophageal cancer	9.77e-05	0.000314	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PSME2—esophageal cancer	9.77e-05	0.000314	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ANXA1—esophageal cancer	9.73e-05	0.000312	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TPI1—esophageal cancer	9.68e-05	0.000311	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTO1—esophageal cancer	9.68e-05	0.000311	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTO1—esophageal cancer	9.59e-05	0.000308	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TPI1—esophageal cancer	9.59e-05	0.000308	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EP300—esophageal cancer	9.55e-05	0.000306	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SST—esophageal cancer	9.46e-05	0.000304	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALDOB—esophageal cancer	9.28e-05	0.000298	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOTCH3—esophageal cancer	9.22e-05	0.000296	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GHRL—esophageal cancer	9.22e-05	0.000296	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALDOB—esophageal cancer	9.2e-05	0.000295	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.08e-05	0.000291	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FBXW7—esophageal cancer	9.07e-05	0.000291	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CA2—esophageal cancer	8.98e-05	0.000288	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GAPDH—esophageal cancer	8.93e-05	0.000287	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GAPDH—esophageal cancer	8.85e-05	0.000284	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CRABP1—esophageal cancer	8.85e-05	0.000284	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CRABP1—esophageal cancer	8.78e-05	0.000282	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GNG7—esophageal cancer	8.42e-05	0.00027	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ADH7—esophageal cancer	8.35e-05	0.000268	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.35e-05	0.000268	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GNG7—esophageal cancer	8.35e-05	0.000268	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MYC—esophageal cancer	8.32e-05	0.000267	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOTCH2—esophageal cancer	8.27e-05	0.000265	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EGFR—esophageal cancer	8.14e-05	0.000261	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CREBBP—esophageal cancer	8.02e-05	0.000257	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALDH2—esophageal cancer	7.89e-05	0.000253	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALDH2—esophageal cancer	7.82e-05	0.000251	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTT1—esophageal cancer	7.5e-05	0.000241	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTT1—esophageal cancer	7.44e-05	0.000239	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP2A6—esophageal cancer	7.42e-05	0.000238	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2A6—esophageal cancer	7.35e-05	0.000236	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TGFBR2—esophageal cancer	7.34e-05	0.000235	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.33e-05	0.000235	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.32e-05	0.000235	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NOS3—esophageal cancer	7.18e-05	0.000231	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CA—esophageal cancer	7.06e-05	0.000227	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ENO1—esophageal cancer	7.03e-05	0.000226	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS1—esophageal cancer	7.03e-05	0.000226	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TYMP—esophageal cancer	7e-05	0.000225	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ENO1—esophageal cancer	6.97e-05	0.000224	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS1—esophageal cancer	6.97e-05	0.000224	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SMAD4—esophageal cancer	6.95e-05	0.000223	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PSME2—esophageal cancer	6.93e-05	0.000222	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PSME1—esophageal cancer	6.93e-05	0.000222	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PSME1—esophageal cancer	6.87e-05	0.00022	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PSME2—esophageal cancer	6.87e-05	0.00022	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—esophageal cancer	6.83e-05	0.000219	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.81e-05	0.000218	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.63e-05	0.000213	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—esophageal cancer	6.57e-05	0.000211	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.33e-05	0.000203	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TPI1—esophageal cancer	6.33e-05	0.000203	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.07e-05	0.000195	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6e-05	0.000192	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP1B1—esophageal cancer	5.98e-05	0.000192	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP1B1—esophageal cancer	5.93e-05	0.00019	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.84e-05	0.000187	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.79e-05	0.000186	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HIF1A—esophageal cancer	5.68e-05	0.000182	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP19A1—esophageal cancer	5.62e-05	0.00018	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP19A1—esophageal cancer	5.57e-05	0.000179	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GNG7—esophageal cancer	5.5e-05	0.000177	CbGpPWpGaD
Donepezil—ACHE—Metabolism—EP300—esophageal cancer	5.46e-05	0.000175	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KDR—esophageal cancer	5.43e-05	0.000174	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.16e-05	0.000166	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HMOX1—esophageal cancer	5.13e-05	0.000165	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOTCH1—esophageal cancer	5.12e-05	0.000164	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.09e-05	0.000163	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.99e-05	0.00016	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCB1—esophageal cancer	4.92e-05	0.000158	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.91e-05	0.000157	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCB1—esophageal cancer	4.88e-05	0.000157	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.85e-05	0.000156	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CREBBP—esophageal cancer	4.64e-05	0.000149	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.6e-05	0.000148	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ENO1—esophageal cancer	4.6e-05	0.000148	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EGFR—esophageal cancer	4.56e-05	0.000146	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PSME1—esophageal cancer	4.53e-05	0.000145	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PSME2—esophageal cancer	4.53e-05	0.000145	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CA—esophageal cancer	4.36e-05	0.00014	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOS3—esophageal cancer	4.16e-05	0.000133	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CA—esophageal cancer	4.04e-05	0.00013	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CA—esophageal cancer	3.96e-05	0.000127	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.91e-05	0.000125	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ERBB2—esophageal cancer	3.89e-05	0.000125	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.69e-05	0.000118	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.68e-05	0.000118	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCND1—esophageal cancer	3.43e-05	0.00011	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.35e-05	0.000108	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN1A—esophageal cancer	3.32e-05	0.000107	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CREBBP—esophageal cancer	3.29e-05	0.000106	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.26e-05	0.000105	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.22e-05	0.000103	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EP300—esophageal cancer	3.16e-05	0.000101	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NOS3—esophageal cancer	2.95e-05	9.45e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NOS3—esophageal cancer	2.92e-05	9.37e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MYC—esophageal cancer	2.75e-05	8.84e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.69e-05	8.65e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGFR—esophageal cancer	2.69e-05	8.65e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.67e-05	8.57e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CA—esophageal cancer	2.34e-05	7.5e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—esophageal cancer	2.26e-05	7.26e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—EP300—esophageal cancer	2.24e-05	7.19e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—EP300—esophageal cancer	2.22e-05	7.13e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.15e-05	6.9e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NOS3—esophageal cancer	1.93e-05	6.18e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.76e-05	5.65e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.66e-05	5.32e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.64e-05	5.27e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—EP300—esophageal cancer	1.47e-05	4.7e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.08e-05	3.48e-05	CbGpPWpGaD
